IBCCES is the global leader in training and certification for healthcare professionals, educators and corporate partners who work with individuals with autism and other cognitive disorders. Our reach extends to more than 2 million people in all 50 states and over 70 countries around the globe. IBCCES Member Learning Community is provided as a free service to all IBCCES members who have completed one or more of our training and certification programs.
Mayo Clinic to lead new radiotracer trial for detecting pancreatic cancer
February 3, 2023
ROCHESTER, Minn. — In an academic-industrial collaboration, Mayo Clinic is assessing in a clinical trial a new radiotracer in pancreatic cancer imaging. As part of the investigation, the new agent, 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 (68Ga-FAPI-46), will be compared with 18-fluorodeoxyglucose (FDG), which is the current standard-of-care radiotracer, in positron emission tomography (PET) imaging of pancreatic cancer. “The research will focus on pancreatic cancer and evaluate whether this radiotracer does what it’s supposed to do, and whether it…
Powered by WPeMatico